TGA’s approval of MDMA and Psilocybin for medical use is a result of ‘renewed interest’
Sky News, February 6, 2023
Neuromedicines Discovery Centre Deputy Director Professor Chris Langmead comments on the TGA’s rescheduling of MDMA and psilocybin.
Australia The First Nation To Approve The Legal Use Of MDMA And Psilocybin
Forbes, February 6, 2023
Following decades hidden in the shadows, psychedelic drugs are at last being recognized by governments around the world as potentially life-saving medicines. Now a recent landmark decision by the Australian Therapeutic Goods Administration (TGA) will soon put that idea into legal practice and make it possible for psychiatrists to prescribe psilocybin and MDMA as early as July of this year.
TGA approves magic mushrooms to treat mental health conditions
6PR Perth, February 6, 2023
The Therapeutic Goods Administration (TGA) has approved the use of psychedelic drugs to treat certain mental health conditions. Drugs such as magic mushrooms and MDMA will be allowed to be prescribed for certain conditions such as depression and PTSD.
Australia will be one of the first countries to recognise psychedelic drugs as medicine. Health Insurance Fund CEO Justin James told Oliver Peterson at Perth Live it is a welcome announcement.
Australia is the first country to allow MDMA and magic mushrooms for medical use
Time Out, February 6, 2023
Following a recent landmark announcement by Australia’s Therapeutic Goods Administration (TGA), specialised psychiatrists will now be able to prescribe MDMA and psilocybin to patients with specific treatment-resistant mental illnesses. The move has been praised by those in the health and medical industry.
VIDEO: Hope For PTSD & Depression Sufferers With MDMA & Psilocybin Treatment
The Project, February 5, 2023
Australia has just become the first country to legalise Magic Mushrooms and MDMA as medicines. It is hoped they’ll soon provide a glimmer of hope for the millions of Aussies living with depression and PTSD. Air Force veteran Michael Raymond and spokesperson for Mind Medicine Australia joins us.
TGA psychedelics decision met with relief, cautious optimism and ‘serious reservations’
ABC News, February 5, 2023
Advocates have welcomed a surprise decision from Australia’s drug regulator to approve two psychedelic drugs for mental health treatment, but some clinicians are concerned the decision may be premature.
TGA approves psilocybin, MDMA for treating depression and PTSD
Prensa Latina News, February 4, 2023
Australia’s medical regulator has passed the use of psychedelics to treat some mental health conditions, making the country one of the first in the world to officially recognize MDMA (ecstasy) and psilocybin as medicines.
Australia’s Rescheduling of MDMA & Psilocybin Could Change…Everything?
The Trip Report, February 4, 2023
Welcome to this week’s Trip Report by Beckley Waves.
The original title of today’s post was “Bridging the Gap” since I sense that the psychedelic field has entered the “slope of creating psychedelic infrastructure” that will bridge the gap between the increasing demand (that is currently turning to the underground) and safely, effectively and legally meeting that demand.
But then Australia went and legalized MDMA and Psilocybin…
VIDEO: Regulator approves two psychedelics for depression & PTSD
ABC News, February 4, 2023
Although advocates have welcomed the surprise decision, some experts fear the move is premature. They are urging caution for the use of therapies they say are promising, but ultimately unproven.
TGA approved psychedelics for mental health may stop ‘backyard prescribing’
News.com.au, February 4, 2023
Video coverage discussing the TGA’s decision to reschedule psilocybin and MDMA for medical use, featuring Brain & Mind Centre Co-Director Professor Ian Hickie.
VIDEO: TGA approves use of psychedelics to treat mental health
ABC News, February 4, 2023
ABC TV News’ coverage of the TGA’s decision to reschedule psilocybin and MDMA for medical use.
Australian approval of MDMA and psilocybin a ‘baby step in the right direction’, medical experts say
The Guardian, February 4, 2023
Psychiatrists have cautiously welcomed the ability to prescribe MDMA and psilocybin, saying it’s a “baby step in the right direction”.
The Therapeutic Goods Administration announced on Friday that, from July, approved psychiatrists would be able to prescribe MDMA (ecstasy) for post-traumatic stress disorder and psilocybin (found in magic mushrooms) for treatment-resistant depression.
MDMA and magic mushrooms to be prescribed by psychiatrists
Cairns Post, February 4, 2023
MDMA and magic mushrooms can now be prescribed by psychiatrists to help treat some mental conditions.
The Therapeutic Goods Administration (TGA) announced on Friday the drugs would be removed from the Poisons Standard prohibited substances to the controlled medicines classification.
Huge News: MDMA & Magic Mushrooms Will Soon Be Legal To Treat PTSD & Depression In Australia
Pedestrian, February 4, 2023
In a world first, the Therapeutic Goods Administration (TGA) has signed off on the use of MDMA and Psilocybin (the chemical compound present in magic mushrooms) for medicinal purposes in Australia. We simply love to see it.
Australia approves MDMA and Psilocybin as Medicines
MM News, February 4, 2023
Australia has announced it will officially recognize MDMA for the treatment of post-traumatic stress disorder (PTSD), and psilocybin, the active ingredient in magic mushrooms, for treatment-resistant depression.
MDMA and Psilocybin Are Approved as Medicines for the First Time
Wired, February 3, 2023
In a world-first, Australia has announced it will officially recognize MDMA and psilocybin as medicines.
MDMA and psilocybin approved by TGA for medical use in Australia
7 News, February 3, 2023
People suffering serious mental health conditions will be able to be prescribed psychedelic drugs MDMA and psilocybin within six months.
The Therapeutic Good Administration made the decision following calls to reclassify the substances, but only specifically authorised psychiatrists will be able to prescribe them.
MDMA and psilocybin approved to treat some mental health conditions from July 1
9 News, February 3, 2023
MDMA and psilocybin have been approved to treat some mental health conditions by Australia’s health regulatory body.
The Therapeutic Goods Administration (TGA) has approved the prescription of MDMA for treating post-traumatic stress disorder and psilocybin (the active ingredient in magic mushrooms) for treatment-resistant depression from July 1.
MDMA and magic mushrooms approved for medical use in Australia after TGA ruling
Sky News, February 3, 2023
MDMA and psilocybin have been approved for use by psychiatrists to treat people suffering from serious mental health conditions.
The Therapeutic Goods Administration (TGA) on Friday approved the prescription of MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression.
TGA approves psilocybin and MDMA for use in treating depression and PTSD
ABC News, February 3, 2023
Australia’s medical regulator has approved the use of psychedelics to treat some mental health conditions, making the country one of the first in the world to “officially recognise MDMA and psilocybin as medicines”.